Clearance Summary
NORPLANT(R) TROCAR received FDA 510(k) clearance under submission number K903490, sponsored by Wyeth-Ayerst Laboratories, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 1990-11-28.
- Submission: K903490
- Applicant / Sponsor: Wyeth-Ayerst Laboratories, Inc.
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5570
- Decision date: 1990-11-28
Classification & Regulation
This clearance is catalogued under FDA product code FMI and 21 CFR 880.5570, within the General Hospital review panel as a Class II device.